Greffex’s revolutionary FDHI Vector™
Stem Cell Therapy has long been held back by immune rejection problems. With the application of Greffex’s patented Engineered Veto© technology, this field has the potential to advance rapidly.
As with organ and tissue transplantation, the immune system’s natural response to foreign matter is to mount an attack. Unfortunately, this response necessitates general immunosuppressive therapy in most transplant recipients, which leaves them especially vulnerable to everyday pathogens. Greffex’s revolutionary FDHI Vector™, if successfully utilized by stem cell researchers, would prove an invaluable aid in the creation of immune-ready, lab-generated transplantable tissues.